Career Center
AES Connect
Donate
supervisor_account
check_circle
Get Involved
search
search
Search
menu
Menu
Home
About
About AES
Position Statements
Important Messages from AES
Application Deadlines
Feb 2, 2021, 15:11 PM
Mentorship for Clinical Research
Feb 2, 2021, 15:11 PM
EpiPORT Online Training for Clinical Research
Feb 2, 2021, 15:11 PM
Success Stories
Feb 2, 2021, 15:11 PM
Research and Funding Overview
Feb 2, 2021, 15:10 PM
Quality Measures
Feb 2, 2021, 15:10 PM
Billing and Coding
Feb 2, 2021, 15:10 PM
Treatments
Feb 2, 2021, 15:10 PM
Epilepsy Monitoring Units
Feb 2, 2021, 15:09 PM
Position Statements
Feb 2, 2021, 15:09 PM
Clinical Guidance
Feb 2, 2021, 15:07 PM
Substitution of Different Formulations of Antiseizure Medication for the Treatment of Epilepsy
Dec 30, 2020, 12:35 PM
American Epilepsy Society Calls for Immediate Access to Accepted Treatments for Infantile Spasms
Dec 30, 2020, 12:21 PM
American Epilepsy Society Position on Cannabis as a Treatment for Epileptic Seizures
Dec 30, 2020, 12:14 PM
Position Statement on the Use of Valproate by Women of Childbearing Potential
Dec 30, 2020, 12:08 PM
Position Statement on SUDEP Counseling
Dec 30, 2020, 10:46 AM
Telehealth Position Statement
Dec 30, 2020, 09:45 AM
An Important Message From AES
Dec 30, 2020, 09:33 AM
Susan S. Spencer, MD
Dec 30, 2020, 09:10 AM
Ernst L. Niedermeyer, MD
Dec 30, 2020, 08:58 AM
«
11
12
13
14
15
16
17
18
19
20
»
Announcement: New Physician Specialty Code for Epileptologists
We are pleased to announce the implementation of a new physician specialty code-F6, used to indicate the specialty designation for an epileptologist.
July 24, 2024
AES Leadership Role in Development of a National Plan for Epilepsy in Support of IGAP Goals
AES invites steering committee to lead community-wide consensus process to draft a nat'l plan for epilepsy, incorporating input from all stakeholders.
July 18, 2024
FDA Safety Warning on the Cardiac Effects of Lamotrigine: An Advisory from the Ad Hoc ILAE/AES Task Force
Information for clinicians after a safety warning for patients with underlying cardiac disorders/arrhythmias to the PI for lamotrigine.
February 22, 2021
Diversity, Equity, and Inclusion as a Core AES Value: Commitment and Action
The AES Board has created a committee dedicated to accelerating diversity, equity, and inclusion in our Society's work.
February 11, 2021
Underscoring AES Commitments in Challenging Times
January 13, 2021
An Important Message from the American Epilepsy Society on Healthcare Equity and Troubled Times
June 04, 2020